Related references
Note: Only part of the references are listed.Neuropilin 1 and Neuropilin 2 gene invalidation or pharmacological inhibition reveals their relevance for the treatment of metastatic renal cell carcinoma
Aurore Dumond et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2021)
Sarcomatoid Dedifferentiation in Renal Cell Carcinoma: From Novel Molecular Insights to New Clinical Opportunities
Veronique Debien et al.
CANCERS (2020)
Sarcomatoid renal cell carcinoma: biology, natural history and management
Kyle A. Blum et al.
NATURE REVIEWS UROLOGY (2020)
Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma
Brian I. Rini et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Atezolizumab plus bevacizumab versus sunitinib in patients with previously untreated metastatic renal cell carcinoma (IMmotion151): a multicentre, open-label, phase 3, randomised controlled trial
Brian I. Rini et al.
LANCET (2019)
VEGFC acts as a double-edged sword in renal cell carcinoma aggressiveness
Papa Diogop Ndiaye et al.
THERANOSTICS (2019)
New CXCR1/CXCR2 inhibitors represent an effective treatment for kidney or head and neck cancers sensitive or refractory to reference treatments
Maeva Dufies et al.
THERANOSTICS (2019)
Adjuvant Sunitinib for High-risk Renal Cell Carcinoma After Nephrectomy: Subgroup Analyses and Updated Overall Survival Results
Robert J. Motzer et al.
EUROPEAN UROLOGY (2018)
Potential lymphangiogenesis therapies: Learning from current antiangiogenesis therapies-A review
Michael Yamakawa et al.
MEDICINAL RESEARCH REVIEWS (2018)
Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma
R. J. Motzer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Renal Cell Carcinoma in von Hippel-Lindau Disease-From Tumor Genetics to Novel Therapeutic Strategies
Emily Kim et al.
FRONTIERS IN PEDIATRICS (2018)
Renal Cell Carcinoma in the Era of Precision Medicine: From Molecular Pathology to Tissue-Based Biomarkers
Sabina Signoretti et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Tumor-Associated Lymphatic Vessels Upregulate PDL1 to Inhibit T-Cell Activation
Lothar C. Dieterich et al.
FRONTIERS IN IMMUNOLOGY (2017)
Sunitinib Stimulates Expression of VEGFC by Tumor Cells and Promotes Lymphangiogenesis in Clear Cell Renal Cell Carcinomas
Maeva Dufies et al.
CANCER RESEARCH (2017)
Hypoxia, Hypoxia-inducible Transcription Factors, and Renal Cancer
Johannes Schoedel et al.
EUROPEAN UROLOGY (2016)
Resistance to sunitinib in renal clear cell carcinoma results from sequestration in lysosomes and inhibition of the autophagic flux
Sandy Giuliano et al.
AUTOPHAGY (2015)
Final results from the large sunitinib global expanded-access trial in metastatic renal cell carcinoma
M. E. Gore et al.
BRITISH JOURNAL OF CANCER (2015)
The CXCL7/CXCR1/2 Axis Is a Key Driver in the Growth of Clear Cell Renal Cell Carcinoma
Renaud Grepin et al.
CANCER RESEARCH (2014)
Mechanisms of lymphatic metastasis
Sinem Karaman et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
The Relevance of Testing the Efficacy of Anti-Angiogenesis Treatments on Cells Derived from Primary Tumors: A New Method for the Personalized Treatment of Renal Cell Carcinoma
Renaud Grepin et al.
PLOS ONE (2014)
Autocrine VEGF-VEGFR2-Neuropilin-1 signaling promotes glioma stem-like cell viability and tumor growth
Petra Hamerlik et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Acceleration of clear cell renal cell carcinoma growth in mice following bevacizumab/Avastin treatment: the role of CXCL cytokines
R. Grepin et al.
ONCOGENE (2012)
Lymphangiogenesis: Molecular Mechanisms and Future Promise
Tuomas Tammela et al.
CELL (2010)
Metastatic Sarcomatoid Renal Cell Carcinoma Treated With Vascular Endothelial Growth Factor-Targeted Therapy
Ali Reza Golshayan et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer
Kathy Miller et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Vascular endothelial growth factor mediates intracrine survival in human breast carcinoma cells through internally expressed VEGFR1/FLT1
Tae-Hee Lee et al.
PLOS MEDICINE (2007)
The role of the VEGF-C/VEGFR-3 axis in cancer progression
J-L Su et al.
BRITISH JOURNAL OF CANCER (2007)
Inhibition of lymphogenous metastasis using adeno-associated virus-mediated gene transfer of a soluble VEGFR-3 decoy receptor
JM Lin et al.
CANCER RESEARCH (2005)
Share Paper
